8:00 AM

Transkaryotic Therapies, Inc.
Daniel E. Geffken, SVP Finance & CFO

Biacore International AB
Ulf Jonsson, President

8:35 AM

Powderject Pharmaceutical plc
Steven Harris, Finance Director

Aerogen
Jane Shaw, Chairman & CEO

9:10 AM

Qiagen N.V.
Peer M. Schatz, CFO

Charles River Laboratories
James Foster, CEO & President

9:45 AM

Aventis
Igor Landau, Member of the Board of Management, Chairman of the Supervisory Board of Aventis Pharma

Aviron
Boyd Clarke, Chairman & CEO

10:20 AM

Applied Biosystems
Mike Hunkapiller, President

Dendreon Corporation
Christopher Henney, CEO & Chairman of the Board

10:55 AM

Amgen*
Cary Rosansky, Sr. Director IR

CIMA Labs Inc.
John M. Siebert, President & CEO

11:30 AM

Multiple Sclerosis Panel
Professor Mohammad Sharief Sr. Lecturer & Consultant Neurologist
Guy's Hospital, London

Applied Molecular Evolution, Inc.
William D. Huse, CEO & President

12:30 PM

Lunch - Biotech Analyst Presentations

14:00 PM

Celera Genomics
Peter Barrett, EVP, CBO

United Surgical Partners International Inc.
Mark Kopser, CFO

14:35 PM

Celltech*
Dr. Peter Fellner, CEO

Inhale Therapeutic Systems, Inc.*
Brigid Makes, CFO

15:10 PM

Ciphergen Biosystems, Inc.
William E. Rich, President & CEO

Evotec Biosystems AG
Dirk Ehlers, CFO

15:45 PM

Pharmacopeia, Inc.
Bruce Myers, CFO

LION bioscience AG
Dr. Friedrich von Bohlen, CEO

16:20 PM

Millennium Pharmaceuticals, Inc.
Kevin Starr, EVP Business Ops. & CFO

Mettler Toledo
William P. Donnelly, VP & CFO

16:55 PM

Cephalon, Inc.
Frank Baldino, Jr., Chairman & CEO

Biosearch Italia SpA
Claudio Quarta, CEO

17:30 PM

Alkermes
James Frates, VP & CFO

Akzo Nobel
Trjeerd Kalff, President, Organon International